drugset / Trial / NCT06034262

Use of a Treated, Devitalized and Sterile Umbilical Cord Amniotic Membrane in the Treatment of PIP Joint Osteoarthritis

NCT06034262 ↗

Phase 2 Recruiting 14 enrolled TBF Genie Tissulaire
NaSingle-groupOpen-labelTreatment

Summary

The aim of this open, prospective, multicenter trial is to evaluate the use of a sterile, devitalized, processed umbilical cord amniotic membrane implant placed in joint interposition in the treatment of PIP joint osteoarthritis.

Timeline

Start
2024-10-07
Primary completion
2026-01
Completion
2026-01

Drugs

EvaluationDrugModalityDoseRoute
Subject SclerFIX-IP Other / unclassified — —

Indications